Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-07-11FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for pravastatin sodium (a generic statin product).
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: Study of the Effects of Blackcurrant Extract and Omega-3 Fats on the Health of the Heart and Blood Vessels
A clinical trial evaluating blackcurrant extract and omega-3 fats for cardiovascular health was withdrawn before completion.
-
FDA approval · 2017-06-30FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (CIPLA USA INC.)
FDA approved a supplemental application for pravastatin sodium submitted by Cipla USA Inc., indicating an approved modification to the gener…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults [Phase 3]
Phase 3 trial updating on calorie restriction and its effects on body composition, disease status, function, and quality of life in older ad…
-
FDA approval · 2017-06-23FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for the combination drug amlodipine and atorvastatin. The product is intend…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-06-16FDA Approved: NIACIN — Original Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's NIACIN generic (nicotinic acid) under ANDA 203899. The approval covers a generic niacin product indicated f…
-
FDA approval · 2017-06-12FDA Approved: EZETIMIBE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s original application for ezetimibe, a generic cholesterol-lowering medication.
-
FDA approval · 2017-06-12FDA Approved: EZETIMIBE — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a generic ezetimibe tablet from Quallent Pharmaceuticals Health LLC under ANDA204331. Ezetimibe lowers cholesterol and is u…
-
FDA approval · 2017-06-12FDA Approved: EZETIMIBE — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's original application for ezetimibe, a generic cholesterol-lowering medication. The approval confirms marketing aut…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART [NA]
A completed clinical trial assessed whether L-Carnitine improves postprandial clearance of triglyceride-rich lipoproteins in HIV patients on…
-
FDA approval · 2017-05-25FDA Approved: COLESTID — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for COLESTID (colestipol hydrochloride) submitted by Pharmacia & Upjohn Company LLC.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Social Forces to Improve Statin Adherence (Study B) [NA]
This completed University of Pennsylvania study evaluated social-forces interventions to improve adherence to statins; results were posted i…
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events [Phase 3]
Phase 3 randomized trial evaluating bococizumab in subjects with hyperlipidemia or mixed dyslipidemia at risk of cardiovascular events has c…
-
FDA approval · 2017-05-12FDA Approved: FENOFIBRIC ACID — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original application for a generic fenofibric acid product manufactured by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: The Effect of Olive Leaf Extract Administration on Cardiovascular Health [NA]
Completed clinical trial evaluating olive leaf extract for cardiovascular risk factors in adults with overweight/obesity and elevated choles…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols [Phase 4]
A Phase 4 trial completed to investigate genetic factors that drive variability in plasma lipid response to plant sterols.
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: The RISAP-study: a Complex Intervention in Risk Communication and Shared Decision-making in General Practice [NA]
This update covers the RISAP-study, a complex intervention in risk communication and shared decision-making in general practice. The study, …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein Production [Phase 2, Phase 3]
This clinical trial update reports the completion of Phase 2 and Phase 3 studies assessing intranasal insulin's effect on hepatic and intest…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Effect of Different Types of Carbohydrates Consumed After Exercise on Blood Fat Levels [NA]
The trial update notes the completion of a clinical study evaluating how different types of carbohydrates consumed after exercise affect blo…
-
CLINICAL_TRIALS research · 2017-05-04Clinical Trial Update: The Effect of a Coloring Prompt on Health Engagement [NA]
A completed University of Pennsylvania study evaluated whether a coloring prompt can increase engagement with preventive health screenings a…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels [Phase 4]
Phase 4 clinical trial evaluating omega-3 fatty acid supplementation in tetraplegic patients with dyslipidemia; the study status is complete…
-
FDA approval · 2017-04-26FDA Approved: EZETIMIBE AND SIMVASTATIN — Original Application (Dr.Reddys Laboratories Inc)
FDA approved a new generic fixed-dose combination of ezetimibe and simvastatin from Dr. Reddy's Laboratories Inc under an Original Applicati…
-
FDA approval · 2017-04-25FDA Approved: CHOLESTYRAMINE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the generic cholestyramine (original application) from Zydus Pharmaceuticals (USA) Inc. This approval enables generic access to…
-
FDA approval · 2017-04-24FDA Approved: PRALUENT — Supplemental Application (Regeneron Pharmaceuticals, Inc.)
The FDA approved a supplemental application for PRALUENT (alirocumab) submitted by Regeneron Pharmaceuticals, Inc., updating the product’s l…
-
FDA approval · 2017-04-07FDA Approved: FENOFIBRATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original application for Fenofibrate (generic), a lipid-lowering drug for hyperlipidemia, hypertriglyceridemia, …